
Klyne
San Francisco, CA, United States klyne.ai From their website, Nov 2026
Work here? Claim this listing
About
Klyne provides AI-powered in silico drug discovery services for startups and academic labs, focused on hit discovery and hit-to-lead optimization. It works in computational drug discovery and molecular prediction for a wide array of drug targets.
Services
Ultra-large virtual screening
Screens billions of compounds to maximize hit rates for hit discovery.
Active learning screening
Uses active learning to reduce compute while maintaining screening accuracy.
KlyneDock
ML-enhanced docking intended to reduce false positives in virtual screening.
HYRDA
Molecular dynamics-driven affinity prediction described as FEP-like accuracy at lower cost.
Klyne FEP
Free-energy perturbation service for affinity prediction and lead optimization.
GenAI optimization
Generative AI tools for multi-parameter optimization, including selectivity and ADMET prediction.
Gen-AI lead optimization
Uses generative AI to optimize selectivity, ADMET, and analog design during hit-to-lead refinement.
- Turnaround
- Reliable results in days
- Days
Capabilities
- Assays and studies
- Virtual screening
- Molecular docking
- Free-energy perturbation
- Affinity prediction
- ADMET prediction
- Scale and capacity
- Billions of compounds
- Billions of molecules
- 33 billion compounds
Modalities and species
- Species and models
- Molecular targets
Industries served
- Drug discovery
Details
- Type
- CRO
- Based in
- San Francisco, CA, United States